Why laboratories are rethinking their analyzer strategy

Hospital and private laboratories are under increasing pressure to deliver faster turnaround, deeper diagnostic insight and better cost control—often at the same time. Traditional analyzer setups, built around separate hematology, immunoassay and chemistry devices, can create siloed workflows and high maintenance overhead. As test volumes grow and more work shifts closer to the point of care, many labs are rethinking what a laboratory analyzer should look like.

AI‑powered CBC and multi‑functional analyzers are at the center of this change. Systems such as Ozelle’s EHBT‑50 و EHBT‑75 combine advanced 7‑diff hematology, complete blood morphology (CBM) and, in the case of EHBT‑50, integrated immunoassay and biochemistry, allowing labs to design more flexible analyzer line‑ups. This helps laboratories choose where to place devices—central lab, satellite lab, emergency department or outpatient area—while maintaining consistent quality.

On the أوزيل site, the hematology and CBC analyzer pages show how AI‑driven EHBT‑50 and EHBT‑75 are positioned for different roles in modern laboratory networks.

What a laboratory analyzer needs to deliver in modern hematology

From a lab manager’s perspective, a hematology or CBC laboratory analyzer must do more than simply produce WBC, RBC and PLT counts. It must:

• Provide reliable 7‑part differential counts with consistent morphology flags
• Handle a wide range of sample types and volumes, including capillary and venous blood
• Integrate into laboratory information systems and automation workflows
• Support reflex and repeat rules, and minimize manual smear review
• Operate with manageable consumable costs and minimal downtime

Modern 7‑diff analyzers such as the EHBT‑50 and EHBT‑75 are designed around مورفولوجيا الدم الكاملة (CBM), where high‑resolution imaging and deep learning models classify cells, detect abnormal populations and generate visual morphology reports. This shifts much of the interpretation burden from human operators to AI‑assisted systems while maintaining review capability.

إن EHBT‑50 product page describes it as a multi‑functional all‑in‑one mini lab with 7‑diff hematology (around 37 parameters), immunoassay and biochemistry, using 30–100 µL of blood per test and delivering combined CBC + panel results in one run. The EHBT‑75 page presents a professional 7‑diff auto hematology analyzer focused on hematology depth, advanced morphology, and high‑quality imaging.

Core roles of laboratory analyzers in a CBC‑centered line‑up

Designing an analyzer line‑up is about assigning clear roles rather than simply buying more machines. For CBC and hematology, three roles typically matter most:

1. High‑throughput central analyzer This is the main hematology engine in the core lab, processing the bulk of routine CBCs and supporting automatic reflex rules for smear review or additional tests. A device like EHBT‑75 fits this role: 7‑diff CBC, deep morphology, and AI‑supported abnormal cell detection in about six minutes per sample.
2. Multi‑functional mini‑lab analyzer This analyzer is placed closer to clinicians—such as in emergency, outpatient, or satellite facilities—and performs CBC, immunoassay and selected biochemistry from a single device. The EHBT‑50 Mini Lab exemplifies this: a 7‑diff CBC analyzer with integrated immunoassay and dry chemistry modules in an all‑in‑one design.
3. Backup and niche analyzers Smaller or specialized analyzers can serve as redundancy, handle unusual sample types or support research projects without interrupting core workflows.

By deliberately assigning roles, labs can balance cost, throughput and depth of information while minimizing manual work.

How AI changes what a “good” laboratory analyzer looks like

AI adoption in hematology is redefining laboratory expectations. Instead of simply requiring “accurate counts,” labs now expect analyzers to provide:

• AI‑assisted morphology Systems like EHBT‑50 and EHBT‑75 use CBM and deep learning to classify blood cells, including NST, NSG, NSH, ALY and PAg, and generate image‑based morphology reports. This improves detection of abnormal populations and reduces dependence on manual microscopy.
• Abnormal flagging and risk markers Parameters such as NLR (neutrophil‑to‑lymphocyte ratio), PLR, atypical lymphocyte counts and reticulocytes provide additional insight into infection, inflammation and hematopoietic response.
• Integrated diagnostic workbench Some analyzers incorporate a built‑in diagnostic workbench or connect to AI workbench software, which consolidates test orders, results and AI guidance in a single interface. EHBT‑75, for example, is promoted with an AI‑assisted workbench that helps clinicians interpret complex CBC patterns more efficiently.
• Standardized workflows for multiple locations AI‑driven interpretation makes CBC results more consistent across shifts and locations, which is essential for laboratories managing satellite sites or supporting remote clinics.

For lab managers choosing a laboratory analyzer, these AI‑related features can directly influence workload, training requirements and the ability to support demanding clinicians in oncology, hematology and critical care.

Designing a laboratory analyzer configuration for different lab sizes

Different laboratories need different analyzer configurations. Below are three typical scenarios.

Single‑site hospital laboratory

A single midsize hospital lab might select:

• One EHBT‑75 (or similar) as the core 7‑diff hematology analyzer in the central lab
• One EHBT‑50 near the emergency department to provide CBC + immunoassay + chemistry panels at the point of care

In this configuration, routine and complex CBCs are centralized, while urgent cases in the ED can be handled locally with full panel results in one run.

Private diagnostic center with satellite locations

A private lab group with satellite sample collection points may:

• Place an EHBT‑75 in the main lab for high‑volume CBC and deep morphology
• Deploy one or more EHBT‑50 analyzers in high‑traffic satellite centers to perform CBC, key biochemistry and immunoassays locally

This reduces transport delays and central lab overload, while still maintaining a single technology stack across the network.

Tiered national or regional system

In a tiered system, regional referral labs can house EHBT‑75 analyzers for advanced cases, while district hospitals or larger clinics use EHBT‑50 mini labs. CBC results remain comparable across sites because AI + CBM and shared parameter sets underpin the line‑up.

Table: EHBT‑50 vs EHBT‑75 as laboratory analyzers

الميزة	EHBT‑50 (Multi‑functional mini lab)	EHBT‑75 (Professional 7‑diff hematology analyzer)
Core focus	CBC + immunoassay + biochemistry	CBC and advanced morphology
CBC parameters	≈37 parameters, 7‑diff + advanced markers	≈37 parameters, 7‑diff + advanced markers
Extra modules	Immunoassay, dry chemistry (and more under development)	أمراض الدم فقط
Typical placement	ED, outpatient, satellite labs	Central labs, tertiary care, oncology
Sample volume	30-100 ميكرولتر	30-100 ميكرولتر
Result time (CBC + morph)	Around 6 minutes	Around 6 minutes
AI and CBM	Full AI + CBM, image‑based morphology	Full AI + CBM with deep morphology

This illustrates how each analyzer can be positioned: EHBT‑50 as a flexible, multi‑functional laboratory analyzer close to patient care, and EHBT‑75 as the morphology‑focused engine of the central hematology lab.

Practical selection criteria when upgrading laboratory analyzers

When planning an analyzer upgrade, lab leaders should focus on several practical criteria.

• Test mix and volume Quantify how many CBCs, panels and emergency tests the lab runs per day, and how this might grow in the next three to five years. High‑volume labs benefit from a dedicated 7‑diff analyzer like EHBT‑75, while facilities with diversified testing might prioritize a multi‑functional analyzer like EHBT‑50.
• Automation and manual workload AI‑based morphology and integrated panels can reduce manual smear review, re‑runs and tube handling. This is especially important where expert morphologists are scarce.
• Space, infrastructure and maintenance Compact analyzers with sealed cartridges and minimal fluidics simplify installation and ongoing maintenance, making them suitable for satellite labs and ED settings.
• Connectivity and multi‑site coordination Modern analyzers should integrate with LIS and support data sharing across sites. This enables standardized QC, consolidated reporting and centralized oversight of analyzer performance.
• Budget and total cost of ownership Upfront analyzer price is only part of the story. Labs should consider reagent consumption, maintenance contracts, downtime risk and the value of AI‑driven efficiency improvements.

By aligning these criteria with clinical and operational goals, labs can create a coherent analyzer strategy instead of accumulating devices ad hoc.

FAQs about laboratory analyzers

What is the most important feature when choosing a hematology laboratory analyzer?

The most important feature is reliable 7‑diff CBC with consistent morphology information and meaningful flags. This combination supports both high‑volume routine work and deeper diagnostic questions from clinicians, reducing the need for frequent manual smear review.

When does it make sense to choose a multi‑functional analyzer instead of a hematology‑only system?

A multi‑functional analyzer is ideal when the laboratory or clinical department needs CBC, immunoassay and basic biochemistry in the same workflow, especially in emergency, outpatient or satellite settings. It simplifies equipment layout and speeds up decision‑making at the point of care.

How does AI change daily work for laboratory staff?

AI reduces manual workload by automating morphology classification, abnormal cell detection and some aspects of result interpretation. Staff still review flagged cases, but spend less time on routine slides and more on complex diagnostics and quality tasks.

Are AI‑based laboratory analyzers difficult to implement?

Most AI‑based analyzers are delivered with integrated software and pre‑configured workflows. Implementation mainly involves interfacing with the LIS, staff training and establishing local QC procedures. Once in place, they operate similarly to traditional analyzers from the user perspective.

How can a lab ensure that a new analyzer will integrate smoothly into existing workflows?

Before purchasing, labs should review connection options with their LIS, examine sample handling requirements, and simulate typical daily workflows. It is also useful to speak with reference labs using the same analyzer to understand any integration challenges and best practices.